<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Headache Pain</journal-id><journal-id journal-id-type="iso-abbrev">J Headache Pain</journal-id><journal-title-group><journal-title>The Journal of Headache and Pain</journal-title></journal-title-group><issn pub-type="ppub">1129-2369</issn><issn pub-type="epub">1129-2377</issn><publisher><publisher-name>Springer-Verlag Italia</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3613229</article-id><article-id pub-id-type="publisher-id">00024</article-id><article-id pub-id-type="doi">10.1007/s101940200024</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original</subject></subj-group></article-categories><title-group><article-title>Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schnider</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Moraru</surname><given-names>Ecaterina</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Vigl</surname><given-names>Marion</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>W&#x000f6;ber</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>F&#x000f6;ldy</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Maly</surname><given-names>Joachim</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Bittner</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="A2"/></contrib><contrib contrib-type="author"><name><surname>Wessely</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Auff</surname><given-names>Eduard</given-names></name><xref ref-type="aff" rid="A1"/></contrib><aff id="A1"><label/>Department of Neurology, Faculty of Medicine, University of Vienna, W&#x000e4;hringer G&#x000fc;rtel 18&#x02013;20, A-1090 Vienna, Austria, e-mail: peter.schnider@univie.ac.at, Tel.: +43-1-40400-3120, Fax: +43-1-40400-31241, , , , AT </aff><aff id="A2"><label/>Department of Physical Medicine and Rehabilitation, Faculty of Medicine, University of Vienna, Vienna, Austria, , , , AT </aff></contrib-group><pub-date pub-type="ppub"><month>9</month><year>2002</year></pub-date><volume>3</volume><issue>2</issue><fpage>93</fpage><lpage>99</lpage><permissions><copyright-statement>&#x000a9; Springer-Verlag Italia 2002</copyright-statement></permissions><abstract id="Abs1"><p> We examined the efficacy of physical therapy and adjunctive botulinum toxin type A (BTX-A) injections in the treatment of cervical headache. We performed a doubleblind, randomised, placebo-controlled study over a 12-week period in a university clinic outpatients department. A total of 33 patients with cervical headache, diagnosed according to International Headache Society classification were enrolled. All patients received standardized physical therapy over a three-week period. Patients were randomised to receive either BTX-A (Botox) or placebo. The BTX-A group received a total dose of 90 mouse units (mu) BTX-A at six trigger points while the placebo group received saline. Pain characteristics were reported in a headache diary. Tenderness in the neck muscles, the sagittal range of motion and biofeedback measurement were also documented. Both groups showed significant improvement in terms of headache severity (<italic>p</italic>&#x0003c;0.05), number of headache-free days (<italic>p</italic>=0.005) and number of headache hours per day (<italic>p</italic>&#x0003c;0.05). Trends towards an increase in the number of headache-free days and a decrease in headache hours per day were observed in the BTX-A group. No major side effects were observed. Physical measures and BTX-A injections are safe and effective in the treatment of cervical headache.</p></abstract><kwd-group xml:lang="en"><kwd>Key words Cervical headache</kwd><kwd>Botulinum toxin type A</kwd><kwd>Physical therapy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag Italia 2002</meta-value></custom-meta></custom-meta-group></article-meta></front><back><fn-group><fn><p>Received: 12 July 2001, Accepted in revised form: 1 July 2002</p></fn><fn><p><italic>Correspondence to</italic> P. Schnider</p></fn></fn-group></back></article>